Preventing Diabetes in Those at Risk by Having a Facilitator and Family Doctor Encourage Healthy Activity and Eating Habits (FLIP)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Nearly six million Canadians are living with an increased risk of diabetes (prediabetes) and approximately 50% of these will develop type 2 diabetes within five years. The investigators wish to help these people change their lifestyle, to prevent them from getting diabetes. Trials have shown that by supporting people with prediabetes to be more active and have healthier eating habits they can halve their risk. However, these interventions were very costly and not performed in Canada. With the help of local Family Physicians and other health professionals (e.g. physiotherapy, psychology, endocrinology, nursing) the investigators have created a less expensive intervention suitable for the Canadian population and health system. The investigators need to perform a study to see whether these modified approaches are practical for Canadians and likely to be effective. People at risk will be invited to participate from family practices that have helped us in the initial stages of this program. Family practices will be randomized to giving either the study intervention or continue with the physician's usual care. People receiving the intervention will have an appointment with their family doctor to discuss their exercise and eating habits and agree changes that are necessary. A prescription detailing these changes will be completed and signed by the family physician and participant. Participants will be given the name of a lifestyle change facilitator (LCF) who will receive a copy of the prescription and contact the participant to help them set achievable goals. The LCF will contact participants once a month for six months to help them achieve these goals. The investigators eventual aim is to test this intervention in a large-scale randomized control trial. To achieve this it is necessary to pilot all aspects of the trial. Information from the pilot study can then be used to design and perform a large-scale study effectively. The investigators hope that eventually the numbers of Canadians progressing to having diabetes will be reduced.
| Condition | Intervention | Phase |
|---|---|---|
|
Prediabetes |
Behavioral: Lifestyle changes |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Single Group Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Prevention |
| Official Title: | Preventing Diabetes With Facilitated Lifestyle Intervention Prescriptions.Phase 2: Pilot Study |
- HbA1c Progression to diabetes [ Time Frame: 6 months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 300 |
| Study Start Date: | July 2012 |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Lifestyle counseling
Green prescription with facilitator support
|
Behavioral: Lifestyle changes
Green prescription with support from facilitator
|
| Usual care |
Behavioral: Lifestyle changes
Green prescription with support from facilitator
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adults aged ≥ 18 years
- HbA1c of 5.7 to 6.4% and/or FPG of 6.1 to 6.9 mmol/l and/or a 2hr 75g OGTT of between 7.8 and 11.0 mmol/l
Exclusion Criteria:
- People with Type I or II diabetes
- Unstable angina
- Uncontrolled congestive heart failure
- Unstable arrhythmia
- Heart valvular disease
- Severe hypertension (systolic ≥ 200 or diastolic ≥ 120)
- Pregnant women or planning pregnancy within two years
- Life expectancy < 1 year
- Waiting for major surgery
- High risk of fracture
- Pregnancy or planning pregnancy
Contacts and Locations| Contact: Martin G Dawes, PhD MD | 604-827-4168 | martin.dawes@ubc.ca |
| Canada, British Columbia | |
| UBC Family Practice | Not yet recruiting |
| Vancouver, British Columbia, Canada, V6T 1Z3 | |
| Contact: Not Agreed Yet | |
| Principal Investigator: Martin G Dawes, PhD MD | |
More Information
No publications provided
| Responsible Party: | University of British Columbia |
| ClinicalTrials.gov Identifier: | NCT01589835 History of Changes |
| Other Study ID Numbers: | 260772 |
| Study First Received: | April 30, 2012 |
| Last Updated: | May 1, 2012 |
| Health Authority: | Canada: Ethics Review Committee |
Additional relevant MeSH terms:
|
Glucose Intolerance Prediabetic State Hyperglycemia Glucose Metabolism Disorders |
Metabolic Diseases Diabetes Mellitus Endocrine System Diseases |
ClinicalTrials.gov processed this record on June 17, 2013